arrow
Back
B

B. Felder

vall d'hebron institut d'oncologia (vhio)

5H-index
16Paper Count
92Citation Count
Published Papers 5
Publication Date
Persistence of BRCA1 and RAD51C methylation after neoadjuvant chemotherapy in high risk TNBC
err2024-10-01
err0
PREAI
errPettitt, S.; Proszek, P.; Torga, G.; Gulati, A.; Llop-Guevara, A.; Jank, P.; Felder, B.; Rodriguez, A.; Cooke, S.; Garcia-Murillas, I.; Ravindran, N.; Alaguthurai, T.; Jones, L.; Roxanis, Y.; Serra, V.; Denkert, C.; Loibl, S.; Haider, S.; Lord, C.; Tutt, A.
errShare
errSave
Association of RAD51 and efficacy outcomes in patients with HER2-negative breast cancer (BC) and homologous recombination deficiency (HRD): Post-hoc analysis of the GeparOla trial
err2024-09-01
err0
PREAI
errVillacampa, G.; Filmann, N.; Fasching, P. A.; Balmana, J.; Karn, T.; Marme, F.; Klare, P.; Mueller, V.; Schem, C.; Fehm, T. N.; Stickeler, E.; Van Mackelenbergh, M.; Felder, B.; Nekljudova, V.; Llop-Guevara, A.; Denkert, C.; Loibl, S.; Serra, V.
errShare
errSave
CDH1 mutations predict resistance to neoadjuvant taxane therapy
err2024-05-02
err0
PREAI
errKnappskog, Stian; Helwa, Reham; Rachakonda, Sivaramakrishna; Gansmo, Liv B.; Denkert, Carsten; Yates, Lucy R.; Solbach, Christine; Untch, Michael; Sinn, Bruno V.; Litmeyer, Anne-Sophie; Ataseven, Beyhan; Huober, Jens; Wedge, David C.; Karn, Thomas; Nikolaienko, Oleksii; Marme, Frederik; Fasching, Peter A.; Eikesdal, Hans Petter; Stickeler, Elmar; Schem, Christian; Jank, Paul; van Mackelenbergh, Marion; Muller, Volkmar; Felder, Baerbel; Holtschmidt, Johannes; Campbell, Peter J.; Loibl, Sibylle; Lonning, Per
errShare
errSave
mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC) Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial
err2019-02-15
err10
PREAI
errLoibl, S.; Sinn, B. V.; Karn, T.; Untch, M.; Treue, D.; Sinn, H-P; Weber, K. E.; Hanusch, C. A.; Fasching, P. A.; Huober, J.; Zahm, D-M; Jackisch, C.; Thomalla, J.; Blohmer, J-U; Marme, F.; Klauschen, F.; Rhiem, K.; Felder, B.; von Minckwitz, G.; Burchardi, N.; Schneeweiss, A.; Denkert, C.
errShare
errSave
Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immunecheckpoint blockade and chemotherapy to predict response within the GeparNuevo trial
err2019-02-15
err1
PREAI
errSinn, B. V.; Loibl, S.; Karn, T.; Untch, M.; Kunze, C. A.; Weber, K. E.; Treue, D.; Wagner, K.; Hanusch, C. A.; Klauschen, F.; Fasching, P. A.; Huober, J.; Zahm, D-M; Jackisch, C.; Thomalla, J.; Blohmer, J-U; van Mackelenbergh, M.; Rhiem, K.; Felder, B.; von Minckwitz, G.; Burchardi, N.; Schneeweiss, A.; Denkert, C.
errShare
errSave